Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Similar documents
Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016

Ohio s Medical Marijuana Control Program

Medical Cannabis MATT WEBSTER DO, MS

Substitute HB 523 Outline

The Legalization of Medical Marijuana and the Impact on the Workplace

Medical Marijuana Update Chris Belletieri, DO

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Medical Marijuana: Coverage Considerations for the Buckeye State. ISCEBS & CSHRM Education Session April 20, 2018

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

MEDICAL CANNABIS IN MINNESOTA

MEDICAL MARIJUANA: Can Cannabis Still Get You Canned?

INITIAL PATIENT INTAKE FORM

Medical Marijuana Consent Form

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

Use of Cannabinoids in Medical Practice

Medicinal Cannabis. Patient Log Book. Record your cannabis use and find the right dose

Coordinated Student Health Services. Medical Marijuana/ Low THC Cannabis Use To Qualified Students In Schools Policy

The Shifting Federal Regulation of Cannabis Products

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine

Workplace Issues Associated with Legalized Marijuana. James B. Yates, Esq., SHRM-SCP, SPHR

MEDICAL CANNABIS IN MINNESOTA

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

City of Coral Gables Planning and Zoning Staff Recommendation

Consumer Information Cannabis (Marihuana, marijuana)

THE COMPLETE CBD GUIDE

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Susan Audino, PhD S.A. Audino & Associates, LLC

CBD and Your Health.

8/31/2016. Workplace Implications of Marijuana in the US. Goal

Medical Marijuana Update

Smoke and Mirrors: Navigating Medical Marijuana in the Workplace

A look at Marijuana in 2014

An HR Perspective: Medical Marijuana and How it Affects Employers

DESCRIPTION DURATION

Medical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Is the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young

Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE

Navigating the Rapidly Changing World of Marijuana and the Workplace. January 16, 2018

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research

PREVENTING MARIJUANA USE AMONG YOUTH & YOUNG ADULTS

Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana

AGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up

MINNESOTA S MEDICAL CANNABIS PROGRAM

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

Weeding Through the Workplace Impact of Medical Marijuana

These documents were created to support the work of the Coalition of Colorado Campus Alcohol and Drug Educators. We welcome prevention teams at

Minnesota Medical Cannabis Program. October 24, 2017

Global Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

Act 16 and Medical Cannabis in Pennsylvania

Northern California Chapter, ACP Update In Medicine

Pennsylvania s Medical Marijuana Act and the Creation of a New Protected Class of Employees. Agenda

The Department must establish a minimum of three regions within the state for the purpose of granting permits to growers/processors and dispensaries.

WELCOME TO THEORY WELLNESS CUSTOMERS. Committed to wellbeing through cannabis.

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Consent Presentation: Industrial Hemp Research Pilot Program

THOUGHTS FROM WASHINGTON STATE

Leading a budding industry into the future

Medical vs Recreational Use of Cannabis. 11 th December 2017

Medical Marijuana: The Move to Schedule II

December 2018 Brief Explanation of Proposition 2 and Compromise Bill Passage

Research on Cannabis and PD: Is there any evidence?

Maine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014

Susan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice

INTRODUCTION WHAT IS MARIJUANA 2/28/2018

IMPLICATIONS FOR MEDICAL MARIJUANA LEGALIZATION IN OHIO

WELCOME TO THEORY WELLNESS PATIENTS. Committed to wellbeing through cannabis.

Therapeutic Cannabis in New Hampshire. Number to text: Goals/Objectives. Survey. WMUR Granite State Poll (February 2013) 3/29/2018

ASSEMBLY APPROPRIATIONS COMMITTEE STATEMENT TO. ASSEMBLY COMMITTEE SUBSTITUTE FOR ASSEMBLY, No STATE OF NEW JERSEY DATED: APRIL 5, 2018

Imagine having a son who would punch

What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

Cannabis Use: Scope of the Issue

Medical Marijuana in the Workforce. What This Is...And What It Isn t

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

James Donaldson CEO and Executive Director

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil?

Cannabidiol, or CBD, Benefits for Pain, Mental Illness & Anxiety

Medical Cannabis: A Patient Primer

Medical Marijuana (Cannabis) and Workplace Drug Testing and Safety. Joel Blanchard MD FACEP

Perkins Middle School

Overview of Cannabis Laws

12/19/2017. Medical Marijuana on Campus: Employment and Student Conduct Implications. Without getting into the weeds. Scheduling

Cannabis for RDNs (Who Don t Know their CBD from their THC!)

MEDICAL MARIJUANA AND HEALTH CARE FACILITIES

In New York State. Highly Worth It OR Not??? Medical Marijuana. The Truths 3/29/2018. True or False???

full spectrum hemp products

Q's &A's of Medical Cannabis in Illinois

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Scottsdale Certification Center Health History Questionnaire. Name Gender M / F Date. Date of Birth / / Phone Ht: ft in Wt. Residential Address

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015

The Cannabis Legal Landscape Today. Erika Lietzan University of Missouri School of Law November 2018

Transcription:

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C

Outcome Participants will be able to list 3 approved medical conditions Participants will have basic understanding of regulations for recommending medical marijuana Participant will recognize preconceptions related to medical marijuana Participants will gain a greater understanding of legal issues associated with recommending medical marijuana

Changes are Coming House Bill 523 Approved: May 10, 2016 by House, 71-26; May 25, 2016 by Senate, 18-15 Signed into law by Governor John Kasich on June 8, 2016 Effective: Sep. 8, 2016 Available: September 8, 2018 to Recommend Shifting the paradigm from marijuana the drug to marijuana the medicine

Background Federally Illegal State Approved Lack of Knowledge Bias

Ogden Report Ogden (2009), is a report that is frequently referred to by legal experts when discussing legal ramifications associated with marijuana. David Ogden, Deputy Attorney General, 2009, released a memo stating that the Department of Justice continues to be committed to the Controlled Substance Act being enforced in all states. Moreover, the Department of Justice memo explains the focus has changed, and are not interested in prosecuting those who legally obtain marijuana for medical or legal purpose, as outlined in state guidelines. The memo provides minimal information regarding legal ramifications, and lacks guidance regarding federal statute for medical professionals recommending use of marijuana for medical purpose.

How Marijuana Works Some history: THC, is the main active chemical in marijuana. When smoked, THC quickly passes through the lungs and into the bloodstream, thus carrying it to various organs -- including the brain where the bulk of cannabinoid receptors reside. The Endocannabinoid (EC) system is found in many areas of the brain, which explains why it affects so many different body functions. Cannabinoids exert their influence by regulating how cells communicate how they send, receive, or process messages. The cannabinoids will then slow down communication between cells (The Science of Marijuana, Para 3-6). Twenty years later, scientists identified the sites in the brain and body where marijuana acts and called them cannabinoid (CB) receptors.

Who can Recommend Physicians Nurse Practitioners in New York, Maine, Massachusetts, and Washington Training-2 hr CEU-annually Nurse Practitioners Role Follow-up with patient (Side effects) Mandatory Patient Registration Cash Based-No Insurance http://codes.ohio.gov/oac/4731-32

Approved Medical Conditions Acquired Immunodeficiency Syndrome (AIDS) Positive status for HIV Pain that is chronic; severe or intractable Cancer Chronic traumatic encephalopathy Crohn s disease Epilepsy or another seizure disorder Glaucoma Hepatitis C Inflammatory bowel disease Multiple sclerosis Parkinson s disease Post-traumatic stress disorder Sickle cell anemia Amyotrophic lateral sclerosis

Compare Benefits Disadvantage Decreased symptoms such as: Nausea Spasticity Neuropathic pain Decreased intraocular pressure associated with glaucoma Reduction of chronic pain Erratic absorption Paranoia behavior Panic attacks Cannabis dependence syndrome Cannabinoid hyperemesis syndrome Depression disorders

What Forms Will Be Available "Only the following forms of medical marijuana may be dispensed under this chapter: oils, tinctures, plant material, edibles, patches." The smoking or combustion of medical marijuana is prohibited while vaporization is permitted. (https://www.legislature.ohio.gov/legislation/legislation-summary?id=ga131-hb-523 2016).

Bud or Whole Plant How much can be recommended The law allows for a maximum of a 90- day supply, amount to be determined during the rule-making process. The law prohibits the cultivation of medical marijuana for personal, family, or household use."

Concerns Detriment to society Legal Ramifications Opioids or Medical Marijuana? Addiction Stigma Perception

Delta-9- Tetrahydrocannabinol or (THC) Psychoactive cannabinoid Mild to moderate pain relief, relaxation, insomnia and appetite stimulation. THC has been demonstrated to have antidepressant effects. The majority of strains range from 12-21% THC with very potent and carefully prepared strains reaching even higher. Average THC potency is about 16-17% in Northern CA. Recent research that suggests patients with a predisposition to schizophrenia and anxiety disorders should avoid high-thc cannabis.

Cannabidiol or (CBD) Was legal OTC, now ILLEGAL in Ohio OTC Can provide relief for chronic pain due to muscle spasticity, convulsions and inflammation Offering relief for patients with MS, Fibromyalgia and Epilepsy Some researchers feel it provides effective relief from anxiety-related disorders CBD has also been shown to inhibit cancer cell growth when injected into breast and brain tumors in combination with THC

Screening Compliance Obtain UTOX Opioids and Medical Marijuana OARRS

Positive Urine Test?? If the product contains ONLY CBD and has had the THC removed, then an individual being tested would NOT be expected to test positive for marijuana or marijuana metabolite, https://www.thecannabist.co/2017/03/10/marijuana-drug-testcbd-cannabidiol-positive/74014/

Implications for Practice Diligence Industry-awareness

Summary HB 523-legalization medical marijuana Approved Medical Conditions Legal Issues Stigma, perception, concerns Educate Self

Questions

Disclaimer This presentation is informational only and is not meant to take the place of education or provide legal advice related to recommending medical marijuana.

References Drug Enforcement Agency (DEA) (2016) Drug fact sheet: Drug fact sheet: Marijuana. Retrieved from https://www.dea.gov/druginfo/drug_data_sheets/marijuana.pdf House Bill 523, General Assembly: 131. (https://www.legislature.ohio.gov/legislation/legislationsummary?id=ga131-hb-523 2016). Ogden, D. W. (2009, October 19). Investigation and prosecution in states authorizing the medical use of marijuana. Washington, D. C.: U. S. Department of Justice. Ohio Board of Nursing. (2015). Ohio workforce data summary report October 2015. Retrieved from http://www.nursing.ohio.gov/pdfs/workforce/2015rn/aprn %20Workforce%202015%20FINAL.pdf National Institute on Drug Abuse. (2017, August). What is the scope of marijuana use in the United States? Retrieved from https://www.drugabuse.gov/publications/researchreports/marijuana/what-scope-marijuana-use-in-united-states 201711051109281062157154

References Cont. Nkansah-Amankra, S., & Minelli, M. (2016). "Gateway hypothesis" and early drug use: Additional findings from tracking a population-based sample of adolescents to adulthood. Preventative Medicine Reports, 4, 131-141. 201706041548451591623903 U.S. Department of Veterans Affairs. (2018). VA and marijuana-what veterans need to know. Retrieved from https://www.publichealth.va.gov/marijuana.asp http://cannagramma.com/wpcontent/uploads/2015/10/understandingcannabis.pdf https://www.thecannabist.co/2017/03/10/marijuana-drug-testcbd-cannabidiol-positive/74014/ https://medicalmarijuana.procon.org/view.resource.php?resou rceid=000881#ohio